Brain Circuits Behind Placebo Pain Relief: New Research Reveals How the Brain Naturally Fights Pain

Scientists have identified specific brain circuits responsible for the placebo effect in pain relief, confirming that the phenomenon has a measurable biological basis rather than being purely psychological. This breakthrough, reported in mid-April 2026, stems from research conducted by a multi-institutional team led by Matthew Banghart, an associate professor at the University of California San Diego’s School of Biological Sciences.

The team mapped the neural pathways and neurochemical processes underlying placebo analgesia, demonstrating that expectation of pain relief activates defined brain circuits that then suppress pain signals. Their work represents the first direct linkage between placebo studies in humans and mice, enabling future preclinical research to be more directly translated into clinical applications for people.

Central to the identified circuit are neurons in the ventrolateral periaqueductal gray (vlPAG) region of the brainstem. Fluorescent imaging in mouse models showed these pain-regulating neurons, labeled in green, with visible cell bodies and axon extensions projecting toward the brainstem to inhibit pain transmission. The vlPAG has long been implicated in pain modulation, but this research specifies its precise role in placebo-driven analgesia through endogenous opioid signaling.

Critically, the researchers found that placebo-induced pain relief is not limited to the conditioned stimulus but generalizes across different types of pain, including injuries that occur after the initial placebo training. This broad applicability suggests therapeutic potential for conditions beyond the specific context in which the expectation was formed, supporting the idea that harnessing this pathway could offer opioid-free strategies for managing various pain disorders.